ABCL: AbCellera Corp Sotuvga nisbatan narx
Karl Hansen jamoasi benuqson ilmiy ob’ektga ega, garchi tadqiqot va ishlanmalar (R&D) rentabelligi muddatlari uzoq bo‘lib qolayotgan bo‘lsa-da. Ushbu GURU.Markets grafigidagi joriy P/S ko‘rsatkichi baholash tendentsiyasini vizuallashtiradi, bunda 55.80 ushbu parametrning miqdorini aks ettiradi. AI texnologiyalari sog‘liqni saqlash gigantlari uchun antitanalar kashf etishni tezlashtirmoqda, asoschining super-ovozli aksiyalar orqali nazorati esa AbCellera Biologics (ABCL) platformasining barqaror boshqaruvini ta’minlaydi.
AbCellera Corp (ABCL) kompaniyasining tahliliy kesimlari
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning xususiy kapitalga nisbati AbCellera Biologics|ABCL - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati AbCellera Bio|ABCL - Kompaniya qarzlari|Qarzning balans kapitallashuviga nisbati AbCellera Corp|ABCL - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzi AbCellera|Shoshilinch likvidlik abcellera.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
ABCL - Kompaniyaning sof foydasi|Kutilayotgan sof daromad AbCellera Biologics|ABCL - P/E multiplikatori|Forvard P/E multiplikatori AbCellera|ABCL - Narx-foyda va o‘sish multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati AbCellera Corp|ABCL - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bir aksiya uchun foyda AbCellera|ABCL - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi abcellera.com|ABCL - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi AbCellera Biologics
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning fundamental tahlili:abcellera.com ABCL
P/S koeffitsienti AbCellera Biologics (ABCL) kompaniyasining bozor qiymatini uning yillik daromadiga nisbatan belgilaydi, bu esa qarz yukining ta'sirisiz aktivning haddan tashqari qimmat baholanganligini baholash imkonini beradi. Narxning savdoga nisbati metrikasini tahlil qilish orqali investor ilmiy tadqiqotlarning uzoq muddatli qoplash sikllarini hisobga olgan holda, Carl Hansen jamoasining yuqori obro'si va antitellar platformasining salohiyati joriy multiplikatorlarni qanday asoslashini ko'rishi mumkin.
AbCellera Biologics raqobatchilari
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA Bio - P/S multiplikatori|PTGX - P/S multiplikatori|IMVT: P/S multiplikatori|KNSA (kiniksa.com) - Narxning daromadga nisbati|GRFS (Grifols) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Adaptive Biotech (ADPT)|P/S multiplikatori CLDX|AUPH - Sotuvga nisbatan narx|Narxning daromadga nisbati BioCryst BCRX|veratx.com - Narxning daromadga nisbati|DNTH - Narxning daromadga nisbati|PHVS: Narxning daromadga nisbati|TRML: P/S multiplikatori|Sotuvga nisbatan narx Precigen Corp (PGEN)|Narxning daromadga nisbati Pharming Group N.V.|NKTR: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori UPB|P/S multiplikatori Zenas Bio (ZBIO)|Immunome Corp - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati GOSS|KalVista Pharmaceuticals - P/S multiplikatori|SEPN: Narxning daromadga nisbati|PVLA: P/S multiplikatori|SVRA - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Rigel Pharmaceuticals Inc|Sotuvga nisbatan narx AnaptysBio Inc. ANAB|Narxning daromadga nisbati Astria Therapeutics (ATXS)|Narxning daromadga nisbati ENGN (engene.com)|Narxning daromadga nisbati RAPT Therapeutics RAPT|Aerovate Therapeutics, Inc. (JBIO) - Sotuvga nisbatan narx|Aclaris - P/S multiplikatori|Narx/daromad multiplikatori Kyverna Therapeutics, Inc (KYTX)|TLSA: P/S multiplikatori|CABA - Narx/daromad koeffitsiyenti|VTYX (Ventyx Biosciences, Inc.) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Theratechnologies, Inc. (THTX)|Narxning daromadga nisbati Avalo Therapeutics Inc. (AVTX)|Narx/daromad koeffitsiyenti Eledon Pharmaceuticals, Inc|P/S multiplikatori AGEN (Agenus)|P/S multiplikatori climbbio.com CLYM|Zura Bio - P/S multiplikatori|ATYR: Narxning daromadga nisbati|ADAG: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Ikena Oncology|Narxning daromadga nisbati Shattuck Labs Inc|Narxning daromadga nisbati EQ|Narxning daromadga nisbati Connect Biopharma (CNTB)|IMUX: Narxning sotuvga nisbati|P/S multiplikatori ATRA (Atara Bio)|Bozor kapitallashuvining daromadga nisbati IFRX|X4 Pharmaceuticals - P/S multiplikatori|ACET - P/S multiplikatori|celularity.com (CELU) - Narxning daromadga nisbati|INmune Bio Inc - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Barinthus Bio|Kapitalizatsiyaning daromadga nisbati Kezar Life Sciences Inc (KZR)|P/S multiplikatori SABS|P/S multiplikatori akaritx.com (AKTX)|Enlivex Therapeutics Ltd. - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati QTTB|GeoVax Labs Inc - P/S multiplikatori|Narx/daromad koeffitsiyenti Edesa Biotech Corp EDSA|iBio, Inc. (IBIO) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Carisma Therapeutics Inc.|Narxning daromadga nisbati XTL Biopharmaceuticals Ltd.|Kapitalizatsiyaning daromadga nisbati Bolt Bio (BOLT)|Kapitalizatsiyaning daromadga nisbati HCWB (HCW Biologics Inc.)|P/S multiplikatori aptevotherapeutics.com (APVO)|Narxning daromadga nisbati AIM ImmunoTech Inc. AIM|ADTX: Kapitalizatsiya va daromad nisbati|GRI Bio - P/S multiplikatori|Sotuvga nisbatan narx XORTX Therapeutics Inc|HIND: P/S multiplikatori|Revelation Biosciences Corp (REVB) - P/S multiplikatori|INDP (Indaptus Therapeutics) - P/S multiplikatori|Narxning daromadga nisbati SCNI|P/S multiplikatori CALI|Kapitalizatsiyaning daromadga nisbati affimed.com AFMD|P/S multiplikatori ALLK (Allakos)|HOOKIPA Pharma, Inc. (HOOK) - Sotuvga nisbatan narx|IGMS - Narxning daromadga nisbati|ITOS: Narxning daromadga nisbati|Ocean Biomedical (OCEA) - Narxning daromadga nisbati|TCBP (TC BioPharm (Holdings) Plc) - Narxning daromadga nisbati|THRD (Third Harmonic Bio, Inc) - P/S multiplikatori
